Kymera Therapeutics develops oral medicines for immune and inflammatory diseases using targeted protein degradation. It last closed at $115.31 on Nov 20, down 3.42% on the day. The next earnings report for KYMR is expected around Tue, Jan 12, 2027. For the quarter ended Sep 2026, KYMR reported EPS of -$1.32 on revenue of $0, with revenue down 100.0% from a year ago. Over its last 8 reports the stock moved an average of 2.2% the session after earnings. Over the last 12 months KYMR insiders bought $172.5M of stock on the open market and sold $465.0M, according to SEC Form 4 filings.
AI Auto Pilots
Is KYMR in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold KYMR.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on KYMRStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
KYMR · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 9% below its 20 day and 2% below its 50 day average. It is 13% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 41). The nearest support is the Pivot S1 at $113.27, and the nearest resistance the swing high (Oct 21) at $115.75.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 5.6%/day
Key levels
$142.9252 week high+23.9%
$126.1620 day average+9.4%
$118.47Pivot R1+2.7%
$117.5750 day average+2.0%
$116.43Pivot+1.0%
$115.99100 day average+0.6%
$115.75Swing high (Oct 21)+0.4%
$115.31Last close
$113.27Pivot S1−1.8%
$112.77Swing low (Sep 4)−2.2%
$100.57200 day average−12.8%
$63.6952 week low−44.8%
Indicators
RSI (14)
41.06
Middle of its range
Neutral
MACD
1.15
Below its signal line
Bearish
Stochastic
8.3
Near the bottom of its range
Oversold
ADX (14)
25.1
Trending down
Williams %R
-96.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-112.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−12.5%
Change over 10 sessions
Bearish
ATR (14)
$6.46
Typical daily range, 5.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityNormal, 10.5%/day
Key levels
$142.9252 week high+23.9%
$126.1620 day average+9.4%
$118.47Pivot R1+2.7%
$117.5750 day average+2.0%
$116.43Pivot+1.0%
$115.99100 day average+0.6%
$115.75Swing high (Oct 21)+0.4%
$115.31Last close
$113.27Pivot S1−1.8%
$112.77Swing low (Sep 4)−2.2%
$100.57200 day average−12.8%
$63.6952 week low−44.8%
Indicators
RSI (14)
53.98
Middle of its range
Neutral
MACD
7.62
Below its signal line
Bearish
Stochastic
59.8
Middle of its range
Neutral
ADX (14)
32.0
Trending up
Williams %R
-67.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
43.5
Oversold below −100, overbought above 100
Neutral
Rate of change
+0.3%
Change over 10 sessions
Bullish
ATR (14)
$12.12
Typical daily range, 10.5% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for KYMR
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how KYMR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow KYMR usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for KYMRHow many large options trades hit KYMR, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in KYMR in the last 90 days.
From SEC Form 4 filings by KYMR's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether KYMR is in one of them and how their past KYMR trades turned out.
Kymera Therapeutics is a biopharmaceutical company based in Watertown, Massachusetts, that develops oral medicines. It uses targeted protein degradation, a method that taps into the body's own cell recycling system to remove proteins that cause disease. Its main focus is immunology, with programs aimed at conditions such as atopic dermatitis and asthma, which are often treated with injections. Its medicines are still in clinical testing and are intended for patients with these conditions.